International Journal of Reproductive BioMedicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
Vol. 16, No. 11, 2018, pp. 679-682
Bioline Code: rm18082
Full paper language: English
Document type: Research Article
Document available free of charge
International Journal of Reproductive BioMedicine, Vol. 16, No. 11, 2018, pp. 679-682
© Copyright 2018 - International Journal of Reproductive BioMedicine
The correlation between insulin-like growth factor binding protein 1 (IGFBP-1) and homeostasis model assessment of insulin resistance (HOMA-IR) in polycystic ovarian syndrome with insulin resistance|
Firmansyah, Arini; Chalid, Maisuri Tadjuddin; Farid, Retno Budiati & Abdullah, Nusratuddin
Background: The underlying etiology of polycystic ovarian syndrome (PCOS) is
unknown and assumed to have a strong correlation with insulin resistance.
Homeostasis Model Assessment of insulin resistance (HOMA-IR) is a good tool to
assess insulin resistance. Low levels of serum Insulin-like Growth Factor-Binding
Protein-1 (IGFBP-1) in PCOS women led to the hypothesis that hyperinsulinemia in
PCOS inhibits the production of IGFBP-1, which in turn stimulates excessive
Objective: The study is aimed to analyze the correlation between the levels of
IGFBP-1 and HOMA-IR on insulin resistance in PCOS.
Materials and Methods: A cross-sectional study among 105 PCOS women,
including 60 women with insulin resistance were recruited. The mean of IGFBP-1
and HOMA-IR were 6.507±4.7821 μg/l and 3.633±1.666 respectively.
Results: Low levels of IGFBP-1 were detected in all insulin resistance women.
There was a correlation between HOMA-IR and overweight (p=0.045), while
IGFBP-1 showed no correlation with overweight (p=0.106). In addition, no
correlation between IGFBP-1 with HOMA-IR as a marker of insulin resistance was
Conclusion: Despite the decrease in IGFBP-1, it seems that there is no correlation
between IGFBP-1 with HOMA-IR as a marker of insulin resistance.
Insulin-like growth factor binding protein 1; Insulin resistance; Polycystic ovarian syndrome.
Alternative site location: http://www.ijrm.ir